Johnson Matthey (LON:JMAT) Insider Liam Condon Buys 12 Shares

Johnson Matthey PLC (LON:JMAT) insider Liam Condon purchased 12 shares of the firm’s stock in a transaction dated Wednesday, June 10th. The stock was purchased at an average cost of GBX 1,990 per share, with a total value of £238.80.

Liam Condon also recently made the following trade(s):

• On Monday, June 1st, Liam Condon purchased 4,500 shares of Johnson Matthey stock. The stock was purchased at an average cost of GBX 2,127 per share, with a total value of £95,715.
• On Wednesday, April 15th, Liam Condon purchased 12 shares of Johnson Matthey stock. The stock was purchased at an average cost of GBX 2,022 per share, with a total value of £242.64.

Johnson Matthey Stock Up 0.8%

LON JMAT traded up GBX 16 on Monday, reaching GBX 2,082. The company had a trading volume of 33,354,254 shares, compared to its average volume of 2,908,089. The firm has a market capitalization of £3.49 billion, a price-to-earnings ratio of -36.40, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.93. The company has a debt-to-equity ratio of 69.69, a quick ratio of 0.76 and a current ratio of 1.56. Johnson Matthey PLC has a 1-year low of GBX 1,674 and a 1-year high of GBX 2,434. The company’s fifty day moving average is GBX 2,079.08 and its 200-day moving average is GBX 2,108.85.

Johnson Matthey (LON:JMAT) last announced its earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share for the quarter. The firm had revenue of GBX 1,257.30 billion during the quarter. Johnson Matthey had a negative net margin of 0.76% and a negative return on equity of 4.66%. On average, research analysts forecast that Johnson Matthey PLC will post 173.4112903 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Jefferies Financial Group reaffirmed a “restricted” rating on shares of Johnson Matthey in a report on Friday, May 29th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Johnson Matthey from GBX 2,120 to GBX 2,400 and gave the stock a “buy” rating in a research report on Friday, May 29th. UBS Group reissued a “neutral” rating and set a GBX 2,200 target price on shares of Johnson Matthey in a research note on Friday, May 22nd. Finally, Berenberg Bank raised their price target on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the stock a “buy” rating in a report on Monday, June 1st. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of GBX 2,298.33.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.